New investment will help further advance future U.S. and global expansion, bringing unique healthcare screening and engagement capabilities to more people.
NAPLES, Fla., Dec. 15, 2022 /PRNewswire/ — Fountain Life, a preventative health and longevity company committed to transforming global healthcare from reactive to proactive, today announced it has secured $15M in funding from Eos Venture Partners, the leading InsurTech investor, and Newcross Healthcare, experts in healthcare including treatment and care at home, based in the United Kingdom. The investment is intended to support Fountain Life, including its integrated insurance business, to transform the healthcare ecosystem while improving future healthcare and its availability in the home and more widely around the globe.
Fountain Life is committed to transforming the current healthcare model and moving the emphasis from reactive to preventive care by using cutting-edge technology to detect asymptomatic diseases early. The company has brought together some of the world’s leading and most innovative physicians and scientists to create a new kind of healthcare that is predictive, preventive, personalized, and data-driven. By leveraging new AI technologies and advanced diagnostic testing to identify conditions such as cancer, cardiac, metabolic, and neurodegenerative disease at the earliest stages, Fountain Life gives members the information and tools to make lifestyle modifications that can help them live longer, happier lives.
